BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27314550)

  • 1. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
    Kim JY; Lee J; Koh JS; Park MJ; Chang UK
    J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
    Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
    J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.
    Harryman WL; Gard JMC; Pond KW; Simpson SJ; Heppner LH; Hernandez-Cortes D; Little AS; Eschbacher JM; Cress AE
    Neoplasia; 2017 Nov; 19(11):919-927. PubMed ID: 28954241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
    Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
    J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
    Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
    J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.
    Owen JH; Komarck CM; Wang AC; Abuzeid WM; Keep RF; McKean EL; Sullivan S; Fan X; Prince MEP
    J Neurosurg; 2018 Mar; 128(3):701-709. PubMed ID: 28430034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a novel chordoma cell line: CH22.
    Liu X; Nielsen GP; Rosenberg AE; Waterman PR; Yang W; Choy E; Sassi S; Yang S; Harmon DC; Yang C; Schwab JH; Kobayashi E; Mankin HJ; Xavier R; Weissleder R; Duan Z; Hornicek FJ
    J Orthop Res; 2012 Oct; 30(10):1666-73. PubMed ID: 22504929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
    Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
    Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chordoma-derived cell line U-CH1-N recapitulates the biological properties of notochordal nucleus pulposus cells.
    Fujita N; Suzuki S; Watanabe K; Ishii K; Watanabe R; Shimoda M; Takubo K; Tsuji T; Toyama Y; Miyamoto T; Horiuchi K; Nakamura M; Matsumoto M
    J Orthop Res; 2016 Aug; 34(8):1341-50. PubMed ID: 27248133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cancer stem-like cells in chordoma.
    Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
    J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
    Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
    Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chordomas: A review with emphasis on their pathophysiology, pathology, molecular biology, and genetics.
    Karpathiou G; Dumollard JM; Dridi M; Dal Col P; Barral FG; Boutonnat J; Peoc'h M
    Pathol Res Pract; 2020 Sep; 216(9):153089. PubMed ID: 32825957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of primary and recurrent sacral chordoma on the motor and nociceptive function of hindlimbs in rats: an orthotopic spine model.
    Sarabia-Estrada R; Ruiz-Valls A; Shah SR; Ahmed AK; Ordonez AA; Rodriguez FJ; Guerrero-Cazares H; Jimenez-Estrada I; Velarde E; Tyler B; Li Y; Phillips NA; Goodwin CR; Petteys RJ; Jain SK; Gallia GL; Gokaslan ZL; Quinones-Hinojosa A; Sciubba DM
    J Neurosurg Spine; 2017 Aug; 27(2):215-226. PubMed ID: 28598292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor.
    DeComas AM; Penfornis P; Harris MR; Meyer MS; Pochampally RR
    J Bone Joint Surg Am; 2010 May; 92(5):1231-40. PubMed ID: 20439670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of a primary human chordoma xenograft model.
    Siu IM; Salmasi V; Orr BA; Zhao Q; Binder ZA; Tran C; Ishii M; Riggins GJ; Hann CL; Gallia GL
    J Neurosurg; 2012 Apr; 116(4):801-9. PubMed ID: 22283186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in the operative management of dedifferentiated sacral chordomas.
    Kayani B; Sewell MD; Hanna SA; Saifuddin A; Aston W; Pollock R; Skinner J; Molloy S; Briggs TW
    Neurosurgery; 2014 Sep; 75(3):269-75; discussion 275. PubMed ID: 24867206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
    Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
    J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.
    Kato S; Gasbarrini A; Ghermandi R; Gambarotti M; Bandiera S
    Eur Spine J; 2016 May; 25 Suppl 1():251-6. PubMed ID: 27052403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.